Somatosensory evoked potential and clinical changes after electrode implant in basal ganglia of parkinsonian patients

Muscle and Nerve

Volumn 32, Issue 6, 2005, Pages 791-797

  Insola, Angelo ^a   Mazzone, Paolo ^a   Valeriani, Massimiliano ^b  

^a Centro Traumatologico Ortopedico   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Basal ganglia; Deep brain stimulation; N20; N30; Parkinson's disease; Somatosensory evoked potential

Indexed keywords

ADULT; AMPLITUDE MODULATION; ARTICLE; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN ELECTROPHYSIOLOGY; CELL NUCLEUS; CLINICAL ARTICLE; DYSTONIA; ELECTRODE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; MEDIAN NERVE; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; SENSORIMOTOR CORTEX; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS; SYMPTOMATOLOGY; TREMOR;

BASAL GANGLIA; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; MALE; MEDIAN NERVE; MIDDLE AGED; PARKINSON DISEASE; REACTION TIME; TIME FACTORS;

EID: 28544444981     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20430     Document Type: Article

References (40)

1. Abbruzzese G, Berardelli A. Sensorimotor integration in movement disorders. Mov Disord 2003;18:231-240.
2. Abbruzzese G, Dall'Agata D, Morena M, Reni L, Favale E. Abnormalities of parietal and prerolandic somatosensory evoked potentials in Huntington's disease. Electroencephalogr Clin Neurophysiol 1990;77:340-346.
3. Albe-Fessard D, Tasker R, Yamashiro K, Chodakiewitz J, Dostrovsky J. Comparison in man of short latency averaged evoked potentials recorded in thalamic and scalp hand zones of representation. Electroencephalogr Clin Neurophysiol 1986;65:405-415.
4. Allison T, McCarthy G, Wood CC, Jones SJ. Potentials evoked in human and monkey cerebral cortex by stimulation of the median nerve. A review of scalp and intracranial recordings. Brain 1991;114:2465-2503.
5. Barba C, Frot M, Guenot M, Mauguiere F. Stereotactic recordings of median nerve somatosensory-evoked potentials in the human pre-supplementary motor area. Eur J Neurosci 2001;13:347-356.
6. Barba C, Valeriani M, Restuccia D, Colicchio G, Faraca G, Tonali P, et al. The human supplementary motor area-proper does not receive direct somatosensory inputs from the periphery: data from stereotactic depth somatosensory evoked potential recordings. Neurosci Lett 2003;344:161-164.
7. Barba C, Valeriani M, Colicchio G, Tonali P, Restuccia D. Parietal generators of low- and high-frequency MN (median nerve) SEPs; data from intracortical human recordings. Clin Neurophysiol 2004;115:647-657.
8. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao D, Hommel M, et al. Long-term suppression of tremor by chronic stimulation of the ventralis intermediate thalamic nucleus. Lancet 1991;337:403-406.
9. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 2004;7:587-588.
10. Cheron G, Piette T, Thiriaux A, Jacquy J, Godaux E. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave. Electroencephalogr Clin Neurophysiol 1994;92:491-501.
11. de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001;293:1164-1166.
12. de la Fuente-Fernandez R, Schulzer M, Stoessl AJ. The placebo effect in neurological disorders. Lancet Neurol 2002;1:85-91.
13. de la Fuente-Fernandez R, Schulzer M, Stoessl AJ. Placebo mechanisms and reward circuitry: clues from Parkinson's disease. Biol Psychiatry 2004;56:67-71.
14. Garcia PA, Aminoff MJ, Goodin DS. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease. Neurology 1995;45:989-992.
15. Greene PE, Fahn S. Status of fetal tissue transplantation for the treatment of advanced Parkinson disease. Neurosurg Focus 2002;13:e3.
16. Hanajima R, Dostrovsky JO, Lozano AM, Hutchison WD, Davis KD, Chen R, et al. Somatosensory evoked potentials (SEPs) recorded from deep brain stimulation (DBS) electrode in the thalamus and subthalamic nucleus (STN) Clin Neurophysiol 2004;115:424-434.
17. Huttunen J, Teravainen H. Pre- and postcentral cortical somatosensory evoked potentials in hemiparkinsonism. Mov Disord 1993;8:430-436.
18. Insola A, Le Pera D, Restuccia D, Mazzone P, Valeriani M. Reduction in amplitude of the subcortical low- and high-frequency somatosensory evoked potentials during voluntary movement: an intracerebral recording study. Clin Neurophysiol 2004;115:104-111.
19. Insola A, Rossi S, Mazzone P, Pasqualetti P. Parallel processing of sensory inputs: an evoked potentials study in Parkinsonian patients implanted with thalamic stimulators. Clin Neurophysiol 1999;110:146-151.
20. Kakigi R. Somatosensory evoked magnetic fields following median nerve stimulation. Neurosci Res 1994;20:165-174.
21. Klostermann F, Funk T, Vesper J, Curio G. Spatiotemporal characteristics of human intrathalamic high-frequency (>400 Hz) SEP components. Neuroreport 1999;10:3627-3631.
22. Klostermann F, Gobbele R, Buchner H, Curio G. Dissociation of human thalamic and cortical SEP gating as revealed by intrathalamic recordings under muscle relaxation. Brain Res 2002;958:146-151.
23. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bass JF, Broussolle E, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation Lancet 1995;345:91-95.
24. Limousin-Dowsey P, Pollak P, Van Blercom N, Krack P, Benazzouz A, Benabid A. Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease. J Neurol 1999;246(suppl 2):42-45.
25. Mauguiere F, Broussolle E, Isnard J. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1993;88:243-254.
26. Mauguiere F, Desmedt JE, Courjon J. Astereognosis and dissociated loss of frontal or parietal components of somatosensory evoked potentials in hemispheric lesions. Detailed correlations with clinical signs and computerized tomographic scanning. Brain 1983;106:271-311.
27. Mazzone P, Stanzione P, Stefani A, Bassi A, Gattoni G, Altibrandi MG, et al. Contemporary bilateral targeting of Gpi and STN by "Maranello" stereotactic system for deep brain stimulation in Parkinson's disease. In: Proceedings of 11th European Congress of Neurosurgery, Copenhagen (Denmark), September 1999. Bologna, Italy: Monduzzi International; 1999. p 729-734.
28. Ozaki I, Shimamura H, Baba M, Matsunaga M. N30 in PD. Neurology 1996;47:304.
29. Pierantozzi M, Mazzone P, Bassi A, Rossini PM, Peppe A, Altibrandi MG, et al. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients. Clin Neurophysiol 1999;110:1700-1707.
30. Restuccia D, Valeriani M, Barba C, Le Pera D, Bentivoglio A, Albanese A, et al. Abnormal gating of somatosensory inputs in essential tremor. Clin Neurophysiol 2003;114:120-129.
31. Rossi S, Tecchio F, Pasqualetti P, Ulivelli M, Pizzella V, Romani GL, et al. Somatosensory processing during movement observation in humans. Clin Neurophysiol 2002;113:16-24.
32. Rossini PM, Babiloni F, Bernardi G, Cecchi L, Johnson PB, Malentacca A, et al. Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients. Electroencephalogr Clin Neurophysiol 1989;74:277-289.
33. Rossini PM, Bassetti MA, Pasqualetti P. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism. Electroencephalogr Clin Neurophysiol 1995;96:236-247.
34. Rossini PM, Traversa R, Boccasena P, Martino G, Passatelli F, Pacifici L, et al. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components. Neurology 1993;43:2495-2500.
35. Tarnecki R, Mempel E, Kolodziejak A, Tarnecka D. Cryopallidotomy in Parkinson disease. Effect on somatosensory potentials. Neurol Neurochir Pol 2000;34:329-338.
36. Topper R, Schwarz M, Podoll K, Domges F, Noth J. Absence of frontal somatosensory evoked potentials in Huntington's disease. Brain 1993;116:87-101.
37. Ulivelli M, Rossi S, Pasqualetti P, Rossini PM, Ghiglieri O, Passero S, et al. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD. Neurology 1999;53:1451-1457.
38. Urasaki E, Wada S, Kadoya C, Yokota A, Matsuoka S, Shima S. Origin of scalp far field N18 of SSEPs in response to median nerve stimulation. Electroencephogr Clin Neurophysiol 1990;77:39-51.
39. Valeriani M, Restuccia D, Barba C, Tonali P, Mauguiere F. Central scalp projection of the N30 SEP source activity after median nerve stimulation. Muscle Nerve 2000;23:1194-1203.
40. Valeriani M, Restuccia D, Di Lazzaro V, Le Pera D, Barba C, Tonali P, et al. Dipolar sources of the early scalp somatosensory evoked potentials to upper limb stimulation. Effect of increasing stimulus rates. Exp Brain Res 1998;120:306-315.